The company is developing a platform of drugs that increase the amount of oxygen in the blood and tissues to treat life threatening conditions. The initial focus are cancer patients treated with radiotherapy. Phase Ib/II clinical trials are in progress for the platform's first drug and have shown therapeutic reversal of tumor hypoxia and evidence of improved survival. They have received orphan drug designation from the US FDA for glioblastoma multiforme and also for sickle cell disease. The company has approved IND’s for stroke and sickle cell disease. The stroke trial is in progress.
Asking Price Available On Request
Sales Available On Request
Profit Available On Request
You May Also Like
Toxicology Laboratory for Sale - Las Vegas NV #469968 posted Jun 8, 2017
- Las Vegas, Nevada, United States
Nevada: Fully Functional 4,000 sq foot toxicology confirmation lab with staff, clean CLIA and NV license, more than 3000 samples/month and growing, LIS Medicare, Medicaid for TX, GA, WV, OH, AZ, NV, and UT. Agilent 6460 LCMS and supporting equipment. Asking $4.2 Million
Pre-Clinical CRO with Patents #466338 posted Apr 11, 2017
- San Diego, California, United States
With its patented technology, this company is helping to solve a $302 billion per year ophthalmic problem in the United States. It holds the exclusive license to patented technology for manufacturing implants and the use of the implants for producing experimental retina diseases in the large mammalian...
Profitable MRI Medical Diagnostic Business #399024 posted Jan 25, 2016
- Los Angeles, California, United States
Considerable cash flow, this profitable MRI, medical diagnostic imaging business located in close proximity to a number of area hospitals and medical offices. The company utilizes state-of-the-art equipment and offers comprehensive diagnostic services. Superior customer service and a great reputation...
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.